These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 10084778)
41. Problems related to systemic glucocorticoid therapy in children. Melo-Gomes JA J Rheumatol Suppl; 1993 Apr; 37():35-9. PubMed ID: 8501750 [TBL] [Abstract][Full Text] [Related]
42. [Glucocorticoids and risk of osteoporosis. On the problem of equivalent dose of desirable and undesirable effects of various glucocorticoids, exemplified by deflazacort]. Rotenberger J; Köbberling J Med Klin (Munich); 1993 Jul; 88(7):432-7. PubMed ID: 8377721 [No Abstract] [Full Text] [Related]
43. Deflazacort. A review of its pharmacological properties and therapeutic efficacy. Markham A; Bryson HM Drugs; 1995 Aug; 50(2):317-33. PubMed ID: 8521761 [TBL] [Abstract][Full Text] [Related]
44. Uses, adverse effects of abuse of corticosteroids. Part I. Imam AP; Halpern GM Allergol Immunopathol (Madr); 1994; 22(6):250-60. PubMed ID: 7892813 [TBL] [Abstract][Full Text] [Related]
45. [Principles of glucocorticoid therapy from the viewpoint of the internist]. Allolio B Z Hautkr; 1989 Nov; 64(11):1038-41. PubMed ID: 2514516 [TBL] [Abstract][Full Text] [Related]
46. Growth hormone in renal transplantation--the mode of action, animal studies, and clinical use. Mehls O; Tönshoff B J Am Soc Nephrol; 1992 Jun; 2(12 Suppl):S284-9. PubMed ID: 1498288 [TBL] [Abstract][Full Text] [Related]
47. Effect of therapy with a new glucocorticoid, deflazacort, on linear growth and growth hormone secretion after renal transplantation. Ferraris JR; Fainstein Day P; Gutman R; Granillo E; Ramirez J; Ruiz S; Pasqualini T J Pediatr; 1992 Nov; 121(5 Pt 1):809-13. PubMed ID: 1432436 [TBL] [Abstract][Full Text] [Related]
48. Promoting growth in chronic inflammatory disease: lessons from studies of the growth plate. Ahmed SF; Sävendahl L Horm Res; 2009 Nov; 72 Suppl 1():42-7. PubMed ID: 19940495 [TBL] [Abstract][Full Text] [Related]
50. Effects of deflazacort immunosuppression on long-term growth and growth factors after renal transplantation. Ferraris JR; Pennisi P; Pasqualini T; Jasper H Pediatr Nephrol; 1997 Jun; 11(3):322-4. PubMed ID: 9203181 [TBL] [Abstract][Full Text] [Related]
51. An analytical review of growth hormone studies in children after renal transplantation. Ingulli E; Tejani A Pediatr Nephrol; 1995; 9 Suppl():S61-5. PubMed ID: 7492490 [TBL] [Abstract][Full Text] [Related]
52. Deflazacort--an alternative to prednisolone? Drug Ther Bull; 1999 Aug; 37(8):57-8. PubMed ID: 10696685 [TBL] [Abstract][Full Text] [Related]
60. Does deflazacort therapy offer any advantages over conventional corticosteroids in children with renal disease? Clark G Pediatr Nephrol; 1997 Jun; 11(3):394. PubMed ID: 9203206 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]